Islet inflammation in type 2 diabetes

Diabetologia

Volumn 59, Issue 4, 2016, Pages 668-672

  Marchetti, Piero ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Beta cells; Chemokines; Cytokines; Inflammation; Macrophages; Type 2 diabetes

Indexed keywords

BETA1 INTERFERON; CD68 ANTIGEN; CHEMOKINE; CHEMOKINE CCL16; CHEMOKINE CCL25; CYTOKINE; EOTAXIN; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 11; INTERLEUKIN 19; INTERLEUKIN 1BETA; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PROTEIN CSF1; PROTEIN LTA; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

CELL DAMAGE; CELL FUNCTION; CELL HETEROGENEITY; CELL INFILTRATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LETTER; LYMPHOCYTE; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREATIC TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; ISLETS OF LANGERHANS; MACROPHAGES;

EID: 84959538517     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3875-x     Document Type: Letter

References (43)

1. Kotas ME, Medzhitov R (2015) Homeostasis, inflammation, and disease susceptibility. Cell 160:816–827
2. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87–91
3. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241–1248
4. Lackey DE, Olefsky JM (2016) Regulation of metabolism by the innate immune system. Nat Rev Endocrinol 12:15–28
5. Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA (2015) Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes 6:598–612
6. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N (2014) Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105:141–150
7. Morris DL (2015) Minireview: emerging concepts in islet macrophage biology in type 2 diabetes. Mol Endocrinol 29:946–962
8. Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370
9. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686–1688
10. Martino L, Masini M, Bugliani M et al (2015) Mast cells infiltrate pancreatic islets in human type 1 diabetes. Diabetologia 58:2554–2562
11. Donath MY, Böni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA (2010) Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab 21:261–267
12. Igoillo-Esteve M, Marselli L, Cunha DA et al (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53:1395–1405
13. Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860
14. Donath MY, Størling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl) 81:455–470
15. Cnop M, Abdulkarim B, Bottu G et al (2014) RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate. Diabetes 63:1978–1993
16. Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56:234–241
17. Halban PA, Polonsky KS, Bowden DW et al (2014) β-Cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab 99:1983–1992
18. Marchetti P, Lupi R, del Guerra S et al (2009) Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care 32(Suppl 2):S178–S183
19. Imai Y, Dobrian A, Morris M, Taylor-Fishwick, Nadler J (2016) Lipids and immune inflammatory pathways of beta cell destruction. Diabetologia. doi:10.1007/s00125-016-3890-y
20. Baltrusch S (2016) Mitochondrial network regulation and its potential interference with inflammatory signals in pancreatic beta cells. Diabetologia doi:10.1007/s00125-016-3891-x
21. Donath MY (2016) Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Diabetologia doi:10.1007/s00125-016-3873-z
22. Khodabandehloo H, Gorgani-Firuzjaee S, Panahi G, Meshkani R (2016) Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction. Transl Res 167:228–256
23. Eguchi K, Manabe I (2013) Macrophages and islet inflammation in type 2 diabetes. Diabetes Obes Metab 15(Suppl 3):152–158
24. Kamata K, Mizukami H, Inaba W et al (2014) Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients. Amyloid 21:191–201
25. Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890
26. Butcher MJ, Hallinger D, Garcia E et al (2014) Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia 57:491–501
27. Campbell-Thompson ML, Atkinson MA, Butler AE et al (2013) The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56:2541–2543
28. Banaei-Bouchareb L, Peuchmaur M, Czernichow P, Polak M (2006) A transient microenvironment loaded mainly with macrophages in the early developing human pancreas. J Endocrinol 188:467–480
29. Gunton JE, Kulkarni RN, Yim S et al (2005) Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337–349
30. Bugliani M, Liechti R, Cheon H et al (2013) Microarray analysis of isolated human islet transcriptome in type 2 diabetes and the role of the ubiquitin proteasome system in pancreatic β cell dysfunction. Mol Cell Endocrinol 367:1–10
31. Taneera J, Lang S, Sharma A et al (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 16:122–134
32. Mahdi T, Hanzelmann S, Salehi A et al (2012) Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab 16:625–633
33. Welsh N, Cnop M, Kharroubi I et al (2005) Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 54:3238–3244
34. Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O (2003) Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 308:474–479
35. Negi S, Jetha A, Aikin R et al (2012) Analysis of β-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture. PLoS One 7, e30415
36. Bosco D, Armanet M, Morel P et al (2010) Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 59:1202–1210
37. Marselli L, Sgroi DC, Bonner-Weir S, Weir GC (2009) Laser capture microdissection of human pancreatic β-cells and RNA preparation for gene expression profiling. Methods Mol Biol 560:87–98
38. Marselli L, Thorne J, Dahiya S et al (2010) Gene expression profiles of β-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One 5, e11499
39. Boni-Schnetzler M, Thorne J, Parnaud G et al (2008) Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93:4065–4074
40. Nackiewicz D, Dan M, He W et al (2014) TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6. Diabetologia 57:1645–1654
41. Maedler K, Schumann DM, Sauter N et al (2006) Low concentration of interleukin-1β induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 55:2713–2722
42. Arous C, Ferreira PG, Dermitzakis ET, Halban PA (2015) Short term exposure of beta cells to low concentrations of interleukin-1β improves insulin secretion through focal adhesion and actin remodeling and regulation of gene expression. J Biol Chem 290:6653–6669
43. Hostens K, Pavlovic D, Zambre Y et al (1999) Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. J Clin Invest 104:67–72